On the Toxicity of Chemotherapy for Breast Cancer—the Need for Vigilance
Author:
Publisher
Oxford University Press (OUP)
Subject
Cancer Research,Oncology
Link
http://academic.oup.com/jnci/article-pdf/98/16/1096/7687648/djj338.pdf
Reference10 articles.
1. Hassett MJ, O'Malley AJ, Pakes JR, Newhouse JP, Earle CC. Frequency and cost of chemotherapy-related serious adverse events in a population sample of women with breast cancer. J Natl Cancer Inst2006 ; 98 : 1108 –17.
2. Shapiro CL, Recht A. Side effects of adjuvant treatment of breast cancer. N Engl J Med2001 ; 334 : 1997 –2008.
3. Simes R, Coates A. Patient preferences for adjuvant chemotherapy of early breast cancer: how much benefit is needed? J Natl Cancer Inst Monogr2001 ; 30 : 146 –52.
4. Murthy VH, Krumholz HM, Gross CP. Participation in cancer clinical trials. JAMA2002 ; 291 : 2720 –6.
5. Savvides P, Terrin N, Erban J, Selker HP. Development and validation of a patient-specific predictive instrument for the need for dose reduction in chemotherapy for breast cancer: a potential decision aid for the use of myeloid growth factors. Support Care Cancer2003 ; 11 : 313 –20.
Cited by 14 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Drug-related problems and its associated factors among breast cancer patients at the University of Gondar Comprehensive Specialized Hospital, Ethiopia: A hospital-based retrospective cross-sectional study;Journal of Oncology Pharmacy Practice;2020-04-06
2. Evolution of modern breast cancer treatment: when less is more;Gland Surgery;2018-08
3. Development of separation technology for the removal of radium-223 from targeted thorium conjugate formulations. Part II: purification of targeted thorium conjugates on cation exchange columns;Drug Development and Industrial Pharmacy;2017-04-27
4. Development of separation technology for the removal of radium-223 from targeted thorium conjugate formulations. Part I: purification of decayed thorium-227 on cation exchange columns;Drug Development and Industrial Pharmacy;2016-09-26
5. Development of separation technology for the removal of radium-223 from decayed thorium-227 in drug formulations. Material screening and method development;Drug Development and Industrial Pharmacy;2015-12-07
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3